| #144 |
Michael A. Sandifer |
— |
4 |
| #144 |
Cuneyt C. Capanoglu |
— |
4 |
| #144 |
Vijay Sabesan |
Schering |
4 |
| #144 |
Wyne P. LEE |
Genentech |
4 |
| #144 |
Karl Willis |
Carnegie Mellon University |
4 |
| #144 |
Gayle Misle |
Unknown |
4 |
| #144 |
Coe Leta Rayne Stafford |
Qwest Communications International |
4 |
| #144 |
Zhuangyu Pan |
Raven Biotechnologies |
4 |
| #144 |
Gregory P. MARECEK |
Amazon |
4 |
| #144 |
Sheila Bernadette Christian |
Salesforce |
4 |
| #144 |
Lori J. Wilson |
Genencor International |
4 |
| #144 |
Lucas Pfister |
Salesforce |
4 |
| #144 |
Richard E. DEMARTINI |
Acuson |
4 |
| #144 |
Patrick Tullmann |
Broadcom |
4 |
| #144 |
Robert Bridenbaugh |
Unknown |
4 |
| #144 |
Photon Rao |
Threshold Pharmaceuticals |
4 |
| #144 |
Marilyn Joyce Schneider Hollinger |
Guidewire Software |
4 |
| #144 |
David L. Bourdet |
Theravance Biopharma R&D Ip |
4 |
| #144 |
Jane Yieh |
Alza |
4 |
| #144 |
Famien Aaron Koko |
Samsara |
4 |
| #144 |
Jay Markello |
Sony |
4 |
| #172 |
Spencer C. Hartman |
Varian |
3 |
| #172 |
Jeffrey D. Reagan |
Amgen |
3 |
| #172 |
David Butler |
Elkem Asa |
3 |
| #172 |
Ben Chal |
Gilead Pharmasset |
3 |
| #172 |
Olivier Nolan-Stevaux |
Amgen |
3 |
| #172 |
Houqiang Yan |
Actuate |
3 |
| #172 |
William E. Jarvis |
Nvent Services Gmbh |
3 |
| #172 |
Brad D. Krueger |
— |
3 |
| #172 |
Jeffrey A. Katz |
— |
3 |
| #172 |
Mahsa Ghapandar Kashani |
— |
3 |
| #172 |
Sebaek Oh |
Kla-Tencor |
3 |
| #172 |
Joseph Karatt |
J.W. Medical Systems |
3 |
| #172 |
Timothy Eller |
Dmg Blockchain Solutions |
3 |
| #172 |
Danielle Zhu |
PayPal |
3 |
| #172 |
Bryant McLaughlin |
Amunix Operating |
3 |
| #172 |
Michael Hartman |
Novartis Ag |
3 |
| #172 |
Elton Cheung |
Groupon |
3 |
| #172 |
Bryant Zhu |
— |
3 |
| #172 |
Nils Kuepper |
Audi Ag |
3 |
| #172 |
Robert M. Stovall |
— |
3 |
| #172 |
Karen L. Wion |
Genentech |
3 |
| #172 |
Joana Li |
Incyte |
3 |
| #172 |
Anne M. Ryan |
Genentech |
3 |
| #172 |
Nikola Ikonomov |
Juniper Networks |
3 |
| #172 |
Jung guen Tak |
Google |
3 |
| #172 |
Tamiko KATSUMOTO |
Genentech |
3 |
| #172 |
Robert P. Ng |
Emc |
3 |
| #172 |
Salvatore P. Trapanese |
— |
3 |
| #172 |
Sid Sampangi |
Palantir Technologies |
3 |